🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the makers of Tylenol, alleging the companies withheld safety concerns that the pain reliever created to pediatric cognitive development.

The lawsuit follows a month after Former President Trump publicized an unproven link between using Tylenol - referred to as acetaminophen - while pregnant and autism in young ones.

Paxton is suing Johnson & Johnson, which formerly manufactured the drug, the sole analgesic suggested for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he claimed they "betrayed America by gaining financially from pain and pushing pills ignoring the potential hazards."

The company states there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, deliberately risking millions to line their pockets," Paxton, a Republican, said.

The manufacturer said in a statement that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its online platform, Kenvue also stated it had "continuously evaluated the applicable studies and there is no credible data that demonstrates a proven link between taking acetaminophen and autism."

Associations acting on behalf of medical professionals and medical practitioners share this view.

ACOG has declared paracetamol - the primary component in acetaminophen - is a restricted selection for pregnant women to address discomfort and elevated temperature, which can present serious health risks if not addressed.

"In more than two decades of investigation on the consumption of acetaminophen in gestation, not a single reputable study has definitively established that the consumption of paracetamol in any stage of gestation results in neurodevelopmental disorders in young ones," the group said.

This legal action cites current declarations from the former administration in arguing the drug is potentially dangerous.

In recent weeks, Trump caused concern from medical authorities when he instructed expectant mothers to "struggle intensely" not to use Tylenol when ill.

Federal regulators then published an announcement that medical professionals should consider limiting the consumption of Tylenol, while also stating that "a direct connection" between the drug and autism in young ones has not been proven.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had pledged in spring to conduct "extensive scientific investigation" that would identify the source of autism spectrum disorder in a short period.

But authorities cautioned that identifying a sole reason of autism - believed by scientists to be the outcome of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism is a form of lifelong neurodivergence and impairment that impacts how persons perceive and interact with the surroundings, and is diagnosed using physician assessments.

In his lawsuit, Paxton - aligned with the former president who is running for the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the science" around acetaminophen and autism.

The case attempts to require the companies "eliminate any promotional materials" that states acetaminophen is reliable for women during pregnancy.

This legal action echoes the complaints of a assembly of mothers and fathers of young ones with autism and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in recently.

Judicial authorities dismissed the lawsuit, declaring investigations from the family's specialists was not conclusive.